Where Tech Meets Bio
Latest News
North Bristol NHS Trust has been named the first European reference site for FUJIFILM Healthcare’s SYNAPSE Pathology system, marking a continuation of their collaboration that …
Read More
Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesis
Inductive Bio has secured $25 million in Series A financing to expand its machine learning platform for small molecule drug discovery. The round was led …
Read More
Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery
Flagship Pioneering has launched Etiome, a biotechnology start-up focused on identifying and drugging biomarkers that correspond to specific stages of disease progression. The company begins …
Read More
Latest News
Twist Bioscience Spins Out Atlas Data Storage with $155M to Commercialize DNA-Based Data Storage
Lantern Pharma Advances AI-Guided Drug into Phase 1b/2 Trial for Triple Negative Breast Cancer
Recursion Reports Positive Early Trial Results for Familial Adenomatous Polyposis
No Clear Winner: 7-Year Brain Study Tests Rival Theories of Consciousness
Nurix Debuts Foundation Model to Predict Novel Binders for Undruggable Targets
Eli Lilly Partners with Creyon Bio in up to $1B AI-Oligonucleotide Deal
Latest Insights
by Dr. Karthik Muthusamy
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
Pharmaceutical companies are dealing with an unprecedented volume of safety data with artificial intelligence moving from theoretical applications to practical solutions in pharmacovigilance. With the …
Read More
by Huzaifa Ali
The Importance of Accurate Patient Matching for AI Projects
Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, its success depends on accurate …
Read More
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
From Our Partners
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Partner Events

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››
Case Studies
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Interviews
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
This South Korean Company is at the Forefront of AI-driven Drug Discovery
Merging AI and Quantum Computing To Boost Drug Discovery
Dr. James Field on Breaking the 'Cognition Barrier' in Antibody Discovery with AI and Robotics
Most Read
How Big Pharma Adopts AI To Boost Drug Discovery
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals
AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry
12 Notable AI-powered Biotech Companies Founded in 2021